The CDC’s Newborn Screening and Molecular Biology Branch, in cooperation with APHL, offers onsite molecular assessment program (MAP) (http://www.aphl.org/aphlprograms/newborn-screening-and-genetics/Pages/Molecular-Assessment-Program.aspx, NBS Molecular Assessment Program) visits to assess the quality of a state newborn screening molecular program. The MAP visits are tailored to the specific needs of the newborn screening program, with guidance in evaluating ongoing or soon to be implemented molecular testing procedures. The MAP team of CDC and state public health laboratory scientists works with laboratory personnel to assess all molecular testing procedures.
Read
MAP Testimonials
Get Started
Review MAP Checklist
Review MAP Visit Timeline
Request a MAP Visit
After the MAP visit, the laboratory director receives a summary report and any resources related to specific molecular testing issues that were discussed during the visit. Findings from MAP assessments inform the CDC’s Newborn Screening and Molecular Biology Branch’s efforts to support newborn screening laboratories.
Follow-Up
Rate your MAP Visit.
For more information contact, Guisou Zarbalian, MS, MPH, Senior Specialist, Newborn Screening & Genetics, 240.485.2736,
guisou.zarbalian@aphl.org or Christopher Greene, PhD, Research Scientist, CDC-NSMBB,
crg0@cdc.gov